Filing Flows › iBio (IBIO) › Q1 FY26 › vs Q4 FY25
iBio (IBIO) Q1 FY26 vs Q4 FY25 (quarter over quarter)
iBio's revenue fell $100K (-50%) from $200K in Q4 FY25 to $100K in Q1 FY26.
iBio, Q1 FY26: revenue $100K, net loss $5.7M, operating cash flow −$5.7M. The chart draws each line against Q4 FY25, the increases inside each band.
Every line
| Line | Q1 FY26 | Q4 FY25 | Change | % |
|---|---|---|---|---|
| Revenue | $100K | $200K | −$100K | -50% |
| Other income, net | $231K | $35K | $196K | +560% |
| Net loss | $5.7M | $5.2M | $557K | +11% |
| Costs & expenses | $6.1M | $5.4M | $653K | +12% |
| Operating costs | $6.1M | $5.4M | $653K | +12% |
| Research & development | $3.5M | $3.2M | $326K | +10% |
| General & admin | $2.5M | $2.2M | $327K | +15% |
| Operating cash sources | $6.1M | $5.0M | $1.1M | +22% |
| Depreciation & amortization | $108K | $126K | −$18K | -14% |
| Share-based compensation | $323K | $270K | $53K | +20% |
| Cash used in operations | $5.7M | $4.6M | $1.1M | +23% |
| Net loss absorbed | $5.7M | $5.2M | $557K | +11% |
| Working capital & other | $376K | −$152K | $528K | — |
Questions
How much did iBio's revenue grow quarter over quarter in Q1 FY26?
iBio's revenue fell $100K (-50%) from $200K in Q4 FY25 to $100K in Q1 FY26.